AU653874B2 - Ethanol adducts of 6-sulfonyl-substituted 3-hydroxy-chromans and their use as inhalants in diseases - Google Patents

Ethanol adducts of 6-sulfonyl-substituted 3-hydroxy-chromans and their use as inhalants in diseases Download PDF

Info

Publication number
AU653874B2
AU653874B2 AU30171/92A AU3017192A AU653874B2 AU 653874 B2 AU653874 B2 AU 653874B2 AU 30171/92 A AU30171/92 A AU 30171/92A AU 3017192 A AU3017192 A AU 3017192A AU 653874 B2 AU653874 B2 AU 653874B2
Authority
AU
Australia
Prior art keywords
ethanol
hydroxy
inhalants
diseases
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU30171/92A
Other languages
English (en)
Other versions
AU3017192A (en
Inventor
Heinrich Englert
Doris Gehring
Paul-Gerhard Kibat
Dieter Mania
Erich Paulus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU3017192A publication Critical patent/AU3017192A/en
Application granted granted Critical
Publication of AU653874B2 publication Critical patent/AU653874B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU30171/92A 1991-12-14 1992-12-11 Ethanol adducts of 6-sulfonyl-substituted 3-hydroxy-chromans and their use as inhalants in diseases Ceased AU653874B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4141350 1991-12-14
DE4141350 1991-12-14

Publications (2)

Publication Number Publication Date
AU3017192A AU3017192A (en) 1993-06-17
AU653874B2 true AU653874B2 (en) 1994-10-13

Family

ID=6447111

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30171/92A Ceased AU653874B2 (en) 1991-12-14 1992-12-11 Ethanol adducts of 6-sulfonyl-substituted 3-hydroxy-chromans and their use as inhalants in diseases

Country Status (19)

Country Link
US (1) US5310753A (enExample)
EP (1) EP0547523B1 (enExample)
JP (1) JP2625071B2 (enExample)
CN (1) CN1073172A (enExample)
AT (1) ATE122674T1 (enExample)
AU (1) AU653874B2 (enExample)
CA (1) CA2085166A1 (enExample)
DE (1) DE59202242D1 (enExample)
DK (1) DK0547523T3 (enExample)
ES (1) ES2073850T3 (enExample)
FI (1) FI925618L (enExample)
HU (2) HUT67172A (enExample)
IL (1) IL104055A (enExample)
MX (1) MX9207216A (enExample)
NO (1) NO300893B1 (enExample)
NZ (1) NZ245447A (enExample)
RU (1) RU2102391C1 (enExample)
TW (1) TW244350B (enExample)
ZA (1) ZA929616B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9510477D0 (en) * 1995-05-24 1995-07-19 Sandoz Ltd Organic compounds
FR2756284B1 (fr) * 1996-11-26 2000-04-28 Adir Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE407724T1 (de) 2002-11-12 2008-09-15 Warner Lambert Co Methode zur stimulierung von haarwuchs auf der basis von benzopyranen

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810488A (en) * 1984-12-19 1989-03-07 Riker Laboratories, Inc. Physically modified beclomethasone dipropionate suitable for use in aerosols
AU3818989A (en) * 1988-07-19 1990-01-25 Hoechst Aktiengesellschaft The use of substituted 3,4-dihydro-2h-benzopyrans as remedies for constructive functional disorders of the lungs and/or disorders of the efferent urinary passages
AU6080090A (en) * 1989-08-10 1991-02-14 Beecham Group Plc Novel compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
FR2633605B1 (fr) * 1988-07-01 1991-07-12 Rhone Poulenc Chimie Procede de preparation d'oxyde de titane et d'articles a base d'oxyde de titane

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810488A (en) * 1984-12-19 1989-03-07 Riker Laboratories, Inc. Physically modified beclomethasone dipropionate suitable for use in aerosols
AU3818989A (en) * 1988-07-19 1990-01-25 Hoechst Aktiengesellschaft The use of substituted 3,4-dihydro-2h-benzopyrans as remedies for constructive functional disorders of the lungs and/or disorders of the efferent urinary passages
AU6080090A (en) * 1989-08-10 1991-02-14 Beecham Group Plc Novel compound

Also Published As

Publication number Publication date
TW244350B (enExample) 1995-04-01
FI925618A7 (fi) 1993-06-15
FI925618L (fi) 1993-06-15
MX9207216A (es) 1993-06-01
JP2625071B2 (ja) 1997-06-25
DK0547523T3 (da) 1995-09-11
NZ245447A (en) 1994-09-27
NO300893B1 (no) 1997-08-11
NO924806L (no) 1993-06-15
DE59202242D1 (de) 1995-06-22
IL104055A0 (en) 1993-05-13
ATE122674T1 (de) 1995-06-15
EP0547523A1 (de) 1993-06-23
EP0547523B1 (de) 1995-05-17
CN1073172A (zh) 1993-06-16
CA2085166A1 (en) 1993-06-15
US5310753A (en) 1994-05-10
ZA929616B (en) 1993-06-18
RU2102391C1 (ru) 1998-01-20
AU3017192A (en) 1993-06-17
FI925618A0 (fi) 1992-12-10
IL104055A (en) 1998-04-05
NO924806D0 (no) 1992-12-11
JPH05255303A (ja) 1993-10-05
ES2073850T3 (es) 1995-08-16
HU9203928D0 (en) 1993-03-29
HUT67172A (en) 1995-02-28

Similar Documents

Publication Publication Date Title
AU674512B2 (en) Peptides having tachykinin antagonist activity
NZ226089A (en) Pyrimidinylamino derivatives of substituted piperidine; pharmaceutical compositions and processes of preparation
TW458970B (en) Benzoylpyridazines having the activity in inhibiting phosphodiesterase IV
JPH04134077A (ja) イソオキサゾール化合物
TW420672B (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines
US5310753A (en) Ethanol adducts of 6-sulfonyl-substituted 3-hydroxy-chromans and their use as inhalants in diseases
DE69429642T2 (de) Lactol-Derivate, als Cathepsin L Inhibitoren
JPH05221980A (ja) アセチレン化合物
GB2092144A (en) Novel indanyl derivaitves
CN108911951A (zh) 一种麝香草酚及其制备方法和药物组合物
JP2716827B2 (ja) ２４ｒ‐スキムノールならびにその製造および使用
SE453293B (sv) 3,3-dialkyl- och 3,3-alkylen-indolinderivat, sett att framstella dessa och farmaceutiska kompositioner innehallande desamma
HUT75341A (en) New salts of 2-[(2,6-dichloro-phenyl)-amino]-phenyl-acetoxy-acetic acid with organic bases, pharmaceutical compns. contg. them and process for preparing the said compds.
JPH06329697A (ja) 骨疾患治療剤
HUP0300604A2 (hu) Eljárás [6-(4-klór-fenil)-2,2-dimetil-7-fenil-2,3-dihidro-1H-pirrolizin-5-il]-ecetsav és polimorfja előállítására és alkalmazásuk
DK155736B (da) Analogifremgangsmaade til fremstilling af 4-(1-imidazolylmethyl)kanelsyre-hydrochlorid-monohydrat
CA1041113A (en) 1,2-diphenyl-ethane derivatives
EP2084158B1 (en) Process for the preparation of crystal forms of cabergoline via novel stable solvates of cabergoline
WO2002060440A1 (en) Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide
JP2852555B2 (ja) 新規な水溶性ビタミンｋ類誘導体およびその製造法
JP2637042B2 (ja) ヒドロキシメチルポリチオフェン誘導体
JP3041049B2 (ja) シス（＋）３−［４，６−ジヒドロキシクロマン−３−イルメチル］−４−メトキシアニリンの製法及び中間体
WO2004087682A1 (en) Novel crystalline forms of parecoxib sodium
JPH0629184B2 (ja) 骨粗鬆症治療剤
JPH06199809A (ja) ２，５−ジブロモピリミジンの製造法

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired